Early Liver Cancer Detection
Blog Early Liver Cancer Detection Early liver cancer detection matters because hepatocellular carcinoma is often found after symptoms appear. For people with known risk factors, regular screening and timely follow-up can help identify concerns earlier and guide next steps with a physician. Why Early Detection Matters Hepatocellular carcinoma (HCC) is one of the most survivable […]
Liver Cancer Blood Test For Early HCC Screening
Blog Liver Cancer Blood Test For Early HCC Screening A liver cancer blood test may help support screening conversations for people at higher risk of hepatocellular carcinoma (HCC), the most common type of primary liver cancer. MoleculeDx focuses on blood‑based testing for early liver cancer detection and is designed to help eligible patients and providers take the next step […]
HCC Screening Test For High-Risk Patients
Blog HCC Screening Test For High-Risk Patients An HCC screening test is used to help monitor people who may be at increased risk of hepatocellular carcinoma — the most common form of primary liver cancer. MoleculeDx provides blood-based testing support for eligible patients as part of a physician-guided screening and follow-up conversation. What Is HCC? Hepatocellular […]
Why AFP Tests Miss Liver Cancer in Half of Patients
Blog Why AFP Tests Miss Liver Cancer in Half of Patients The challenge is not a lack of will. It is a lack of accurate tools. One of the biggest problems is our continued reliance on alpha‑fetoprotein (AFP) testing—a marker that has been used for decades despite one critical flaw: it misses liver cancer in […]